199 related articles for article (PubMed ID: 7495309)
1. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.
Chadburn A; Suciu-Foca N; Cesarman E; Reed E; Michler RE; Knowles DM
Am J Pathol; 1995 Dec; 147(6):1862-70. PubMed ID: 7495309
[TBL] [Abstract][Full Text] [Related]
2. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
[TBL] [Abstract][Full Text] [Related]
3. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.
Weissmann DJ; Ferry JA; Harris NL; Louis DN; Delmonico F; Spiro I
Am J Clin Pathol; 1995 Jun; 103(6):748-55. PubMed ID: 7785662
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of posttransplantation lymphoproliferative disorders.
Chadburn A; Cesarman E; Knowles DM
Semin Diagn Pathol; 1997 Feb; 14(1):15-26. PubMed ID: 9044506
[TBL] [Abstract][Full Text] [Related]
6. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.
Orazi A; Hromas RA; Neiman RS; Greiner TC; Lee CH; Rubin L; Haskins S; Heerema NA; Gharpure V; Abonour R; Srour EF; Cornetta K
Am J Clin Pathol; 1997 Apr; 107(4):419-29. PubMed ID: 9124210
[TBL] [Abstract][Full Text] [Related]
7. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.
Kinch A; Cavelier L; Bengtsson M; Baecklund E; Enblad G; Backlin C; Thunberg U; Sundström C; Pauksens K
Am J Transplant; 2014 Dec; 14(12):2838-45. PubMed ID: 25307322
[TBL] [Abstract][Full Text] [Related]
8. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
9. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
Cesarman E; Chadburn A; Liu YF; Migliazza A; Dalla-Favera R; Knowles DM
Blood; 1998 Oct; 92(7):2294-302. PubMed ID: 9746767
[TBL] [Abstract][Full Text] [Related]
10. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
11. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.
Oudejans JJ; Jiwa M; van den Brule AJ; Grässer FA; Horstman A; Vos W; Kluin PM; van der Valk P; Walboomers JM; Meijer CJ
Am J Pathol; 1995 Oct; 147(4):923-33. PubMed ID: 7573368
[TBL] [Abstract][Full Text] [Related]
12. Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria.
Canioni D; Jabado N; MacIntyre E; Patey N; Emile JF; Brousse N
Histopathology; 2001 Feb; 38(2):146-59. PubMed ID: 11207828
[TBL] [Abstract][Full Text] [Related]
13. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
14. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009.
Yoon SO; Yu E; Cho YM; Suh C; Kim KM; Han DJ; Lee SG; Huh J
Clin Transplant; 2012; 26(1):67-73. PubMed ID: 21269330
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients.
Strazzabosco M; Corneo B; Iemmolo RM; Menin C; Gerunda G; Bonaldi L; Merenda R; Neri D; Poletti A; Montagna M; Del Mistro A; Faccioli AM; D'Andrea E
J Hepatol; 1997 Apr; 26(4):926-34. PubMed ID: 9126809
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
[TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative disease in organ transplant recipients.
Nalesnik MA
Springer Semin Immunopathol; 1991; 13(2):199-216. PubMed ID: 1664986
[No Abstract] [Full Text] [Related]
19. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
[TBL] [Abstract][Full Text] [Related]
20. Donor Monoclonal Gammopathy May Cause Lymphoproliferative Disorders in Solid Organ Transplant Recipients.
Felldin M; Ekberg J; Polanska-Tamborek D; Hansson U; Sender M; Rizell M; Svanvik J; Mölne J
Am J Transplant; 2016 Sep; 16(9):2676-83. PubMed ID: 27575725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
